CHANGING THE POULTRY PROBIOTIC GAME

The global poultry industry is constantly changing and adapting to new challenges and requirements of their farms, including disease pressures, legislative requirements, and consumer demands. As antibiotic use is falling and cage-free production is rising, producers are trying to find products that are effective and safe for birds and consumers. Traditionally, probiotics have been added to chicken feed for daily delivery, but the results have been very inconsistent and show little direct benefit to the birds. NCH Life Sciences has removed this inconsistency in probiotic performance with our ACTPRO™ technology and our ECOcharger™ 1000 system to deliver billions of activated, effective bacteria directly into the drinking water every day at chicken farms.

ACTPRO technology uses Bacillus bacteria combined with our proprietary activation accelerant inside the ECOcharger 1000 unit and delivers the activated bacteria automatically into the drinking water to be consumed by the birds. Bacillus bacteria have the natural ability to pass through the stomach unaffected by pH and enzymatic activity, and the ACTPRO technology is the key to making our Bacillus probiotics activate immediately and begin growing when they reach the small intestine.

The ACTPRO technology is able to deliver significant and measurable benefits to the birds because of the growth of our probiotics throughout the entire gut. These direct benefits include protected villi and microvilli development, competitive exclusion, immune stimulation, and enzyme production for increased digestive efficiency. ACTPRO and ECOcharger are the only technology on the market that can impact the microbiome throughout all parts of the digestive tract.

To our customers, these benefits are manifested in overall improvements in production, including weight gain, survival, and feed conversion efficiency (see study below) – For more information, see our Resources page.

NCH Life Sciences, LLC is a wholly owned subsidiary of NCH Corporation.

Weight Gain FCR Intestinal Lactobacillus population Intestinal Salmonella Population
ECOcharger Treatment 2155.6 1.41 6.00 x 109 0
Control 1996.0 1.58 6.10 x 107 2.5 x 106
Difference: 8.00% (10.76%) 98x more No Salmonella detected
P value <0.01 <0.05 <0.05 <0.01








LifeSciences@nch.com